Lilly launches Tanstrive (Selpercatinib), a RET inhibitor to treat advanced cancers with RET gene…
Available in India in 40 mg, 80 mg, 120 mg and 160 mg tablet strengths; administered orally twice daily
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cancer care
Our aim is to tailor our oncology portfolio to address the most pressing needs in India
Pratima Reddy, Country Speaker for Merck India & MD, Merck Specialties elaborates on the company’s partnerships with national…
SII partners with Univercells for affordable personalised oncology
Univercells and SII believe that they may be able to dramatically accelerate the progress of new medicines
Oncology dominates CRISPR landscape: GlobalData
Oncology accounts for 30 per cent of all active CRISPR drugs
Median Technologies partners with PASREL-Imagerie to deliver imaging biomarkers for oncology drugs
The association aims to develop and implement smart imaging biomarkers to better understand the Mechanism of Action (MOA) of…
Delhi State Cancer Institute and Merck Specialities sign MoU to accelerate access to cancer care
Enter a strategic collaboration to drive awareness, early diagnosis and counselling support to patients and family
Cancer CART therapy: What are the benefits and stakes?
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
By 2030, we want to treat one in five cancer patients in India: Lara Bezerra, MD Roche India
Lara Yumi Tsuji Bezerra, Managing Director, Roche India came to India with close to 24 years of pharma experience, across sales,…
SPJIMR launches programme for NGOs working in cancer care
The one-year 'Organisational Development Programme' is conceived, developed and delivered by SPJIMR’s Centre for Education in the…